To provide a further test of the dual binding site hypothesis proposed for acetylcholinesterase (AChE) inhibitor heptylene-linked bis-(9-amino-1,2,3,4-tetrahydroacridine) A7A, short-tether (ethylene-hexylene) homologs A2A-A6A were prepared. En route to these compounds, convenient and scaleable syntheses of useful pharmaceutical intermediate 9-chloro-1,2,3,4-tetrahydroacridine 3 and A7A were developed. AChE and butyrylcholinesterase (BChE) inhibition assays of A2A-A10A confirm that a seven methylene tether (A7A) optimizes AChE inhibition potency and AChE/BChE selectivity. Finally, these studies indicate that simultaneous binding of alkylene-linked 9-amino-1,2,3,4-tetrahydroacridine dimers to the catalytic and peripheral sites of AChE is poss...
Abstract: Cholinesterases (ChEs) play a vital role in the regulation of cholinergic transmission. Th...
Acetylcholinesterase (AChE) is an essential enzyme that terminates cholinergic transmission by rapid...
Two novel families of dual binding site acetylcholinesterase (AChE) inhibitors have been developed, ...
Tacrine (THA) is approved by the FDA for the palliative treatment of Alzheimer's disease, but its us...
Three series of 4-aminopyridine-and 4-aminoquinoline based symmetrical bivalent acetylcholinesterase...
A series of 1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridines differently substituted at positions 1, 5,...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Alzheimer's Disease (AD) is threatening about 15 million people in 1994 and the number is set to ris...
Dimeric acetylcholinesterase (AChE) inhibitors containing a single 9-amino-1,2,3,4-tetrahydroacridin...
In this study, we have employed in silico methodology combining double pharmacophore based screening...
Two isomeric series of dual binding site acetylcholinesterase (AChE) inhibitors have been designed, ...
Tacrine heterobivalent ligands were designed as novel and reversible inhibitors of cholinesterases. ...
Tacrine-based AChE and BuChE inhibitors were designed by investigating the topology of the active si...
WOS: 000186124200010PubMed ID: 14607022A novel series of bispyridinium-type acetylcholinesterase (AC...
A series of hexahydro-1,6-naphthyridines were synthesized in good yields by the reaction of 3,5-bis[...
Abstract: Cholinesterases (ChEs) play a vital role in the regulation of cholinergic transmission. Th...
Acetylcholinesterase (AChE) is an essential enzyme that terminates cholinergic transmission by rapid...
Two novel families of dual binding site acetylcholinesterase (AChE) inhibitors have been developed, ...
Tacrine (THA) is approved by the FDA for the palliative treatment of Alzheimer's disease, but its us...
Three series of 4-aminopyridine-and 4-aminoquinoline based symmetrical bivalent acetylcholinesterase...
A series of 1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridines differently substituted at positions 1, 5,...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Alzheimer's Disease (AD) is threatening about 15 million people in 1994 and the number is set to ris...
Dimeric acetylcholinesterase (AChE) inhibitors containing a single 9-amino-1,2,3,4-tetrahydroacridin...
In this study, we have employed in silico methodology combining double pharmacophore based screening...
Two isomeric series of dual binding site acetylcholinesterase (AChE) inhibitors have been designed, ...
Tacrine heterobivalent ligands were designed as novel and reversible inhibitors of cholinesterases. ...
Tacrine-based AChE and BuChE inhibitors were designed by investigating the topology of the active si...
WOS: 000186124200010PubMed ID: 14607022A novel series of bispyridinium-type acetylcholinesterase (AC...
A series of hexahydro-1,6-naphthyridines were synthesized in good yields by the reaction of 3,5-bis[...
Abstract: Cholinesterases (ChEs) play a vital role in the regulation of cholinergic transmission. Th...
Acetylcholinesterase (AChE) is an essential enzyme that terminates cholinergic transmission by rapid...
Two novel families of dual binding site acetylcholinesterase (AChE) inhibitors have been developed, ...